Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Neoplasms 4 Solid Cancer 1 Small Cell Lung Carcinoma 1 Prostate Cancer Metastatic 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Advanced Solid Tumor 1

Interventions

enzalutamide 5 Prednisone 5 cabazitaxel 4 Docetaxel 3 Abiraterone Acetate 3 fludrocortisone acetate 1 Zuclomiphene 1 XRP6258 1 Standard of Care 1 Prednisolone 1 Midazolam 1 LY3023414 1 Injections 1 Hydrocortisone 1 Dexamethasone 1 Abituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Prostate Cancer Metastatic × XRP6258 × Clear all

NCT01718353 2017-11-20

TAXYNERGY

Sanofi

Phase 2 Completed

63 enrolled 13 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡